4//SEC Filing
INCARA PHARMACEUTICALS CORP 4
Accession 0001187233-03-000004
CIK 0000936538operating
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 11:17 AM ET
Size
10.7 KB
Accession
0001187233-03-000004
Insider Transaction Report
Form 4
GAMMANS RICHARD E SR
Executive VP, R&D
Transactions
- Award
Incentive Stock Option (right to buy)
2003-07-28+1,575,489→ 1,780,772 totalExercise: $0.15Exp: 2013-07-28→ Common Stock (1,575,489 underlying) - Award
Incentive Stock Option (right to buy)
2003-07-28+205,283→ 1,780,772 totalExercise: $0.15Exp: 2013-07-28→ Common Stock (205,283 underlying) - Award
Non-Qualified Stock Option (right to buy)
2003-07-28+74,511→ 74,511 totalExercise: $0.15Exp: 2013-07-28→ Common Stock (74,511 underlying)
Footnotes (3)
- [F1]Exercisable ratably over 12 months commencing July 28, 2003.
- [F2]229,166 shares exercisable ratably over 5 months commencing July 28, 2003, 475,489 shares exercisable ratably over 12 months commencing January 28, 2004 and 870,834 shares exercisable ratably over 19 months commencing January 28, 2005, based on continued consulting or employment with the Company.
- [F3]Exercisable ratably over 12 months commencing January 28, 2004, based on continued consulting or employment with the Company.
Documents
Issuer
INCARA PHARMACEUTICALS CORP
CIK 0000936538
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000936538
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 11:17 AM ET
- Size
- 10.7 KB